Viracta Therapeutics, Inc. (VIRX) stock is going high in aftermarket – What’ happening?
Mahrukh Rehan
February 1, 2022
Viracta Therapeutics, Inc. (VIRX) experienced an increase of 8.21% in aftermarket following the announcement that the company has dosed the first patient in Phase 1b/2